Invivogen
Menu

IFN-γ Reporter HEK 293 Cells

HEK-Blue™ IFN-γ cells Unit size Cat. code Docs Qty Price
Human HEK293 cells - IFN-γ Reporter Cells
3-7 x 10e6 cells
hkb-ifng
+-
$1,408.00

You may also need : QUANTI-Blue™ | View more associated products

Human Interferon-γ Reporter Cells

HEK-Blue™ IFN-γ Cells signaling pathway
HEK-Blue™ IFN-γ Cells signaling pathway

HEK-Blue™ IFN-γ cells allow the detection of bioactive human interferon-γ (IFN-γ) by monitoring the activation of the JAK/STAT-1 pathway. 
IFN-γ, a Type II IFN, is a pleiotropic cytokine with anti-viral, anti-tumor, and immunomodulatory functions [1].  IFN-γ binds a heterodimeric receptor consisting of two subunits, IFNGR1 and IFNGR2, associated with JAK1 and JAK2, respectively. Upon binding to this receptor, IFN-γ triggers JAK/STAT signaling.  Activated STAT1 molecules form homodimers and are translocated to the nucleus where they bind interferon-gamma-activated sites (GAS) in the promoter of IFN-γ inducible genes.

 More details on interferon-γ

 

Cell line description:

HEK-Blue™ IFN-γ cells were generated by stable transfection of the human embryonic kidney HEK293 cell line with the human STAT1 gene to obtain a fully active STAT1 pathway.

The other genes of the pathway are naturally expressed in sufficient amounts.

These cells were further transfected with a SEAP (secreted embryonic alkaline phosphatase) reporter gene under the control of an ISG54 promoter fused to four interferon-gamma-activated sites (GAS).

HEK-Blue™ IFN-γ cells produce SEAP in response to IFN-γ stimulation only. They are unresponsive to type I IFNs.

Levels of SEAP in the supernatant can be easily determined with QUANTI-Blue™ Solution.


Features of HEK-Blue™ IFN-γ cells:

  • Fully functional IFN-γ signaling pathway
  • Do not respond to IFN-α/β (Type I IFNs)
  • Readily assessable SEAP reporter activity
  • Functionally tested and guaranteed mycoplasma-free


Applications of HEK-Blue™ IFN-γ cells:

  • Detection of human IFN-γ
  • Screening of anti-hIFN-γ antibodies

 

Reference:

1. Ivashkiv L.B., 2018. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 18(9):545-558.

Figures

Response of HEK-Blue™ IFN-γ cells to type I IFNs and IFN-γ
Response of HEK-Blue™ IFN-γ cells to type I IFNs and IFN-γ

Cells were stimulated with increasing concentrations of hIFN-α (IU/ml), hIFN-β (IU/ml), or hIFN-γ (ng/ml). After a 24h incubation, the levels of IFN-induced SEAP were determined using QUANTI-Blue™, a SEAP detection reagent, and by reading the optical density (OD) at 655 nm.

Ligand EC50 Response Ratio
Human IFN-γ 0.7 ng/ml 25

The response ratio was calculated by dividing the OD at 655 nm for the treated cells by the OD at 655 nm for the untreated cells.

Back to the top

Specifications

Antibiotic resistance: blasticidin, Zeocin®

Growth medium: DMEM, 4.5 g/l glucose, 2 mM L-glutamine, 10% (v/v) heat-inactivated fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin, 100 μg/ml Normocin™

Guaranteed mycoplasma-free

Detection range for human IFN-γ: 0.1 - 10 ng/ml

 

This product is covered by a Limited Use License (See Terms and Conditions).

Back to the top

Contents

  • 1 vial containing 3-7 x 106 cells
  • 1 ml of Blasticidin (10 mg/ml)
  • 1 ml of Zeocin® (100 mg/ml)
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipped on dry ice Shipped on dry ice (Europe, USA, Canada and some areas in Asia)

Back to the top

Details

Interferon-gamma (IFN-γ), a Type II interferon, is secreted from CD4+ T-helper 1 (Th1) cells and activated natural killer (NK) cells. It plays a role in activating lymphocytes to enhance anti-microbial and anti-tumor effects [1-3]. In addition, IFN-γ plays a role in regulating the proliferation, differentiation, and response of lymphocyte subsets. 

IFN-γ exerts its action by first binding to a heterodimeric receptor consisting of two chains, IFNGR1 and IFNGR2, causing its dimerization and the activation of specific Janus family kinases (JAK1 and JAK2) [4, 5]. Two STAT1 molecules then associate with this ligand-activated receptor complex and are activated by phosphorylation. Activated STAT1 forms homodimers and are translocated to the nucleus where they bind interferon-gamma-activated sites (GAS) in the promoter of IFN-γ inducible genes.

 

1. Ivashkiv L.B., 2018. IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 18(9):545-558.
2. Shtrichman R. & Samuel CE., 2001. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol. 4(3):251-9.
3. Sato A. et al., 2006. Antitumor activity of IFN-lambda in murine tumor models. J Immunol. 176(12):7686-94.
4. Platanias L.C., 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 5(5):375-86.
5. Schroder K. et al., 2004. Interferon-gamma: an overview of signals, mechanisms, and functions. J Leukoc Biol. 75(2):163-89.

Back to the top

FAQ Cell Lines

Visit our FAQ Any questions about our cell lines ? Visit our frequently asked questions page

Back to the top
Customer Service
& Technical Support
Shopping cart is empty